 IsoPlexis Corp. ISO, 0.36 is primed to go public Friday, after the Connecticut-based biotechnology companys initial public offering priced overnight at 15 a share, in the middle of the expected range of between 14 and 16 a share. The company sold 8.33 million shares in the IPO to raise 125.0 million. 